In vitro and in vivo metabolism of myristicin in the rat

Hye Suk Lee; Tae Cheon Jeong; Jeong Han Kim

doi:10.1016/S0378-4347(97)00531-8

In vitro and in vivo metabolism of myristicin in the rat

Hye Suk Lee
, Tae Cheon Jeong
, Jeong Han Kim

Korea Research Institute of Chemical Technology

Research output: Contribution to journal › Article › peer-review

33 Scopus citations

Abstract

Myristicin [5-allyl-1-methoxy-2,3-(methylenedioxy)benzene] is a flavoring plant constituent and has been known to produce significant psychopharmacological responses as well as insecticidal activity. From in vitro and in vivo metabolism of myristicin, the two metabolites 5-allyl-1-methoxy-2,3-dihydroxybenzene and 1'-hydroxymyristicin were identified using GC-MS after derivatization of sample matrices with a mixture of BSTFA-TMCS. Those metabolites from in vitro study were also confirmed in urine after an oral administration of myrisitcin to rats, and enzymatic hydrolysis of urine suggested that these metabolites were excreted as conjugated forms as well.

Original language	English
Pages (from-to)	367-372
Number of pages	6
Journal	Journal of Chromatography B, Biomedical Applications
Volume	705
Issue number	2
DOIs	https://doi.org/10.1016/S0378-4347(97)00531-8
State	Published - 13 Feb 1998

Bibliographical note

Funding Information:
This paper was supported by Non Directed Research Fund, Korea Research Foundation, 1996.

Keywords

Myristicin

Access to Document

10.1016/S0378-4347(97)00531-8

Cite this

@article{d7e1b6c230e44e07be369e363f84aa3d,

title = "In vitro and in vivo metabolism of myristicin in the rat",

abstract = "Myristicin [5-allyl-1-methoxy-2,3-(methylenedioxy)benzene] is a flavoring plant constituent and has been known to produce significant psychopharmacological responses as well as insecticidal activity. From in vitro and in vivo metabolism of myristicin, the two metabolites 5-allyl-1-methoxy-2,3-dihydroxybenzene and 1'-hydroxymyristicin were identified using GC-MS after derivatization of sample matrices with a mixture of BSTFA-TMCS. Those metabolites from in vitro study were also confirmed in urine after an oral administration of myrisitcin to rats, and enzymatic hydrolysis of urine suggested that these metabolites were excreted as conjugated forms as well.",

keywords = "Myristicin",

author = "Lee, \{Hye Suk\} and Jeong, \{Tae Cheon\} and Kim, \{Jeong Han\}",

note = "Funding Information: This paper was supported by Non Directed Research Fund, Korea Research Foundation, 1996.",

year = "1998",

month = feb,

day = "13",

doi = "10.1016/S0378-4347(97)00531-8",

language = "English",

volume = "705",

pages = "367--372",

journal = "Journal of Chromatography B, Biomedical Applications",

issn = "1572-6495",

publisher = "Elsevier BV",

number = "2",

}

TY - JOUR

T1 - In vitro and in vivo metabolism of myristicin in the rat

AU - Lee, Hye Suk

AU - Jeong, Tae Cheon

AU - Kim, Jeong Han

N1 - Funding Information: This paper was supported by Non Directed Research Fund, Korea Research Foundation, 1996.

PY - 1998/2/13

Y1 - 1998/2/13

N2 - Myristicin [5-allyl-1-methoxy-2,3-(methylenedioxy)benzene] is a flavoring plant constituent and has been known to produce significant psychopharmacological responses as well as insecticidal activity. From in vitro and in vivo metabolism of myristicin, the two metabolites 5-allyl-1-methoxy-2,3-dihydroxybenzene and 1'-hydroxymyristicin were identified using GC-MS after derivatization of sample matrices with a mixture of BSTFA-TMCS. Those metabolites from in vitro study were also confirmed in urine after an oral administration of myrisitcin to rats, and enzymatic hydrolysis of urine suggested that these metabolites were excreted as conjugated forms as well.

AB - Myristicin [5-allyl-1-methoxy-2,3-(methylenedioxy)benzene] is a flavoring plant constituent and has been known to produce significant psychopharmacological responses as well as insecticidal activity. From in vitro and in vivo metabolism of myristicin, the two metabolites 5-allyl-1-methoxy-2,3-dihydroxybenzene and 1'-hydroxymyristicin were identified using GC-MS after derivatization of sample matrices with a mixture of BSTFA-TMCS. Those metabolites from in vitro study were also confirmed in urine after an oral administration of myrisitcin to rats, and enzymatic hydrolysis of urine suggested that these metabolites were excreted as conjugated forms as well.

KW - Myristicin

UR - https://www.scopus.com/pages/publications/0032512681

U2 - 10.1016/S0378-4347(97)00531-8

DO - 10.1016/S0378-4347(97)00531-8

M3 - Article

C2 - 9521577

AN - SCOPUS:0032512681

SN - 1572-6495

VL - 705

SP - 367

EP - 372

JO - Journal of Chromatography B, Biomedical Applications

JF - Journal of Chromatography B, Biomedical Applications

IS - 2

ER -

In vitro and in vivo metabolism of myristicin in the rat

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this